Operating Income: The income after operating expenses.
Charles River Laboratories International, Inc. (CRL) had Operating Income of $133.80M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.00B |
|
$54.42M |
|
$666.06M |
|
$338.79M |
|
$871.05M |
|
|
Operating Income |
$133.80M |
$-46.60M |
|
$87.20M |
|
$87.20M |
|
$55.56M |
|
$55.56M |
|
$55.56M |
|
$55.56M |
|
$133.80M |
|
$218.96M |
|
49.21M |
|
49.43M |
|
$1.11 |
|
$1.10 |
|
| Balance Sheet Financials | |
$1.53B |
|
$1.59B |
|
$5.98B |
|
$7.51B |
|
$1.12B |
|
$2.19B |
|
$2.98B |
|
$4.10B |
|
$3.41B |
|
$-83.05M |
|
$3.41B |
|
49.22M |
|
| Cash Flow Statement Financials | |
$590.13M |
|
$-116.51M |
|
$-484.86M |
|
$205.57M |
|
$209.22M |
|
$3.65M |
|
$53.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.37 |
|
-- |
|
-- |
|
0.39 |
|
0.64 |
|
33.72% |
|
13.32% |
|
13.32% |
|
-- |
|
8.68% |
|
5.42% |
|
$459.92M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
2.20 |
|
1.37 |
|
65.78 |
|
1.63% |
|
-66.89% |
|
0.74% |
|
0.99% |
|
$69.29 |
|
$9.31 |
|
$11.94 |
|